Magellan Rx Report

Our award-winning report provides insights on the industry’s most innovative and groundbreaking managed care solutions for some of the most complex areas of healthcare.

Download our media kit today!

Fall 2023
  • Managed Care Newsstand
  • Tumor DNA Test and Cancer Monitoring
  • Accelerated Approvals Update
  • Prostate Cancer
  • Multiple Myeloma
  • Oncology Supportive Care and Telemedicine
  • Oncology Biosimilar Update
  • Pipeline
Summer 2023
  • Enzyme Replacement Therapy
  • Amyotrophic Lateral Sclerosis
  • Gene Therapy Update
  • Bladder Cancer
  • Accelerated Approvals
  • Medicare Star Clinical Programs
Spring 2023
  • Biosimilars
  • Hemophilia A & B
  • Alzheimer Disease
  • Rare Disease
  • Car- T Therapy
  • Oncology Update
Fall 2022
  • Rheumatoid Arthritis
  • Metastatic Bladder Cancer
  • Gene Therapy
  • Age-Related Macular Degeneration and Diabetic Macular Edema
  • Hereditary Transthyretin Amyloidosis
Summer 2022
  • Biomarker testing
  • Gene Therapy
  • Chronic Heart Failure
  • CAR-T Update
  • Psoriasis: Current treatment landscape and management
Spring 2022
  • Sleep Disorders
  • Multiple Sclerosis
  • Parkinson’s Disease
  • Biosimilar Update
  • Gout Management
  • COVID-19 Update
  • Cervical Cancer
  • Pipeline
Fall 2021
  • Atopic Dermatitis
  • Lupus and Lupus Nephritis
  • Biosimilar Update and Pipeline
  • Alzheimer’s Disease
  • Chronic Kidney Disease
  • Magellan Capability Insight
  • Dry Eye Disease

 

Summer 2021
  • Amyotrophic Lateral Sclerosis

  • Gene Therapies for Rare Diseases

  • HER2+ Metastatic Breast Cancer

  • HIV Update

  • CAR-T Update

  • COVID-19 and Oncology Care

  • Pipeline

Spring 2021
  • COVID-19: Impact on Delivery of Care
  • Wet AMD
  • Mental Health Update
  • Multiple Myeloma
  • Rare Neuromuscular Diseases
  • IV Iron
  • Pipeline
Fall 2020
  • Hemophilia treatment options and gene therapy
  • Muscular dystrophy and spinal muscular atrophy
  • COVID-19 pipeline update
  • Biosimilar landscape and impact
Summer 2020
  • Sickle Cell Disease: Clinical and Management Update
  • Peanut Allergy: Advances in Treatment
  • Asthma Update: Current Guidelines and Treatment Options
  • Oncology Biosimilars: Update and Payer Considerations
  • Managing Obesity: Developing a Successful Weight-Management Program
Spring 2020
  • Autoimmune Diseases

  • Multiple Sclerosis

  • Gene Therapy

  • MRx Navigate
  • Rare Liver Disease Update

Fall 2019
  • Measuring Total Cost of Care
  • Epilepsy: Advances in Treatment and Management
  • Precision Medicine in Oncology
  • Artificial Intelligence: Advances in Healthcare Innovation
  • Pipeline Drug List
Summer 2019
  • Strategies for Staying Ahead of Specialty Drug Trends
  • Medical Oncology Biosimilars
  • Psoriasis Update
  • Leveraging Technology to Improve Medication Adherence and Optimize Health Outcomes
  • Pipeline Drug List
NTRK Spotlight
NTRK Gene Fusions: Tumor-Agnostic Cancer Therapies and the Importance of Testing
  • NTRK Gene Fusions
  • Incidence of NTRK Gene Fusions
  • Inhibitors and Pipeline
  • Gene Fusion Testing
  • NGS Testing: DNA-Based and RNA-Based
Spring 2019
  • Migraine Management
  • Trends in Oncology Management
  • Digital Therapeutics
  • Rare Disease Management
  • Pharmacogenetics in Managed Care
Fall 2018
  • Multiple Sclerosis
  • PI3K Inhibitors Pipeline
  • Multiple Myeloma Treatment
  • PARP Inhibitors in Ovarian Cancer
  • Opioid Use Disorder
Summer 2018
  • Biosimilars
  • High-Cost Therapy Payment Strategies
  • Cystic Fibrosis
  • Asthma
  • Human Immunodeficiency Virus
Spring 2018
  • Orphan Diseases
  • Alzheimer’s Disease
  • The Opioid Crisis
  • Migraine Pipeline & Treatment
Fall 2017
  • CAR-T and Gene Therapies
  • Opioid-Induced Constipation
  • Osteoporosis in the Managed Care Setting
  • Star Ratings and Quality Improvement
  • Variable Fee Schedule Reimbursement
Summer 2017
  • Migraine Treatment
  • PD-1 and PD-L1 Inhibitors
  • Computerized Cognitive Behavioral Therapy
  • Hemophilia
Spring 2017
  • Personalizing Medicine to Transition Oncology Care
  • Type 2 Diabetes
  • Inflammatory Conditions
  • Immune Globulin
Fall 2016
  • Asthma Management
  • HIV
  • PAH
  • Melanoma
  • LARCs
Summer 2016
  • Biosimilars
  • Multiple Myeloma
  • Medical Drug Management Strategies
  • Long-Acting Injectable Antipsychotics
  • Value Based PBM
Spring 2016
  • PCSK9 Inhibitors and Hypercholesterolemia
  • Real-World Studies
  • AMD
  • Medical Pharmacy Expenditures
  • PD-1 Inhibitors
Fall 2015
  • Pulmonary Arterial Hypertension and Pulmonary Fibrosis
  • Treating Opioid Dependency
  • ACOs
  • Evaluating AMD
  • Improving Star Ratings
Summer 2015
  • Hemophilia
  • PCMH Model
  • Site of Care
  • Medical Pharmacy Solutions
  • Medicare Part D Regulations
Spring 2015
  • PCSK9 Inhibitors
  • Next Generation Sequencing
  • Hepatitis C
  • Opioid Dependency
  • Multiple Sclerosis
Fall 2014
  • Hepatitis C Virus
  • Optimizing HAE
  • CLL Treatment
  • Metastatic Melanoma
  • Infliximab Site of Care
Summer 2014
  • Heart Failure Management
  • Immune Globulin Therapy
  • Star Ratings
  • Quality Improvement in Diabetes
Spring 2014
  • Specialty Management Solutions
  • Prostate Cancer
  • Biosimilars
  • Immune Globulin
  • Renal Cell Carcinoma
Fall 2013
  • A New Era of Oncology Management
  • CML
  • Oral Oncology
  • Understanding Hemophilia
Summer 2013
  • New Generation of Specialty Management
  • Gaucher Disease
  • Managing Hereditary Angiodema
  • Neurotoxins
  • Antiplatelet Therapy for ACS
Spring 2013
  • Specialty Management
  • Immune Globulin Therapy
  • Reproductive Therapies
  • Prostate Cancer
  • Adherence in Patients with HIV
Fall 2012
  • Specialty Management Solutions
  • Innovations in Prostate Cancer Treatment
  • Inside a Pioneer ACO
  • Future Impact of Biosimilars
  • Specialty Trends Update
Summer 2012
  • CMS Star Ratings
  • Transitioning to the Pioneer ACO Model
  • Benefits of Motivational Interviewing
  • The PPACA Contraception Mandate
  • Pediatric Buprenorphine Exposure
Spring 2012
  • Managed Care Solutions
  • Cost-Effectiveness of Oral Anticoagulants
  • CMS Stars
  • New MLR Requirements
  • Transitioning to Accountable Care
Fall 2011
  • Managed Care Solutions
  • GLP-1 Agonists
  • CMS Star Ratings
  • The Clinical Benefits of Prior Authorizations
  • Navigating Accountable Care Organizations
Spring 2011
  • Diabetes Management
  • Asthma Controller Medication
  • Type 2 Diabetes
  • Improving Your Star Ratings
  • Effects of Medication Reconciliation on Readmissions